Selected Financial Statement - Liabilities (Tables)

6 Months Ended

Jun. 30, 2026

Payables And Accruals [Abstract]

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following at June 30, 2026 and December 31, 2025 (in thousands):


		As of June 30, 2026				As of December 31, 2025
Accounts payable:
Clinical and regulatory expenses		$	409			$	565
Professional fees			501				927
Selling expenses			2,028				1,721
Manufacturing costs			191				1,466
Non-employee director compensation			1,011				1,018
Other vendors			208				282
Total accounts payable			4,348				5,979
Accrued interest payable, related parties			1,652				1,474
Accrued interest payable			7,522				5,841
Accrued expenses:
Payroll expenses			346				452
Government rebates and other rebates			9,342				8,538
Other accrued expenses			256				331
Total accrued expenses			9,944				9,321
Total accounts payable and accrued expenses		$	23,466			$	22,615

Schedule of other current liabilities

Other current liabilities consisted of the following at June 30, 2026 and December 31, 2025 (in thousands):


	As of June 30, 2026				As of December 31, 2025
Trade discount	$	3,300			$	3,190
Unearned revenue (a)		11,197				13,000
Other current liabilities		1,171				1,375
Total other current liabilities	$	15,668			$	17,565

(a) Refer to Note 3 for further information.

Schedule of other long-term liabilities

Other long-term liabilities consisted of the following at June 30, 2026 and December 31, 2025 (in thousands):


	As of June 30, 2026				As of December 31, 2025
Trade discount	$	10,580			$	12,239
Unearned Revenue		2,244				—
Other long-term liabilities		60				53
Total other long-term liabilities	$	12,884			$	12,292